Assessing the Effect of Electronic Health Record Data Quality on Identifying Patients With Type 2 Diabetes:
Priyanka Dua Sood1, Star Liu2, Harold Lehmann1,2
1Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, United States, 1 443-287-8264.
Electronic health record (EHR) data quality issues significantly impact the identification of patients with type 2 diabetes (T2D) using computable phenotypes. Variations in data completeness, accuracy, and timeliness reduce patient cohort sizes and overlap across definitions.
Area of Science:
- Health Informatics
- Clinical Data Science
- Chronic Disease Management
Background:
- Electronic health records (EHRs) are increasingly vital for healthcare data, necessitating robust data quality assessments.
- Accurate identification of patient populations, such as those with type 2 diabetes (T2D), is crucial for clinical research and operational decisions.
- Existing computable phenotype definitions for chronic conditions may be sensitive to EHR data quality variations.
Purpose of the Study:
- To evaluate the impact of EHR data quality issues on the performance of computable phenotypes for identifying type 2 diabetes (T2D) denominator populations.
- To assess how variations and robustness of phenotypes influence patient cohort identification.
Main Methods:
- Retrospective analysis of EHR data from approximately 208,000 patients with T2D at Johns Hopkins Medical Institution (2017-2019).
- Inclusion of 4 published phenotypes and 1 expert-defined phenotype for T2D.
- Simulation of data quality issues (incompleteness, inaccuracy, timeliness) across diagnosis, medication, and laboratory data types.
Main Results:
- Low population overlap (<23%) observed across different phenotypes.
- Simulated data incompleteness, inaccuracy, and timeliness issues significantly reduced the number of identified patients for each phenotype.
- Phenotype performance varied considerably under induced data quality degradation.
Conclusions:
- EHR data quality significantly affects the ability to reliably identify T2D patient cohorts using computable phenotypes.
- Findings highlight the need for common, robust T2D phenotype definitions to ensure consistency in clinical informatics and healthcare management.
- This study informs future efforts to standardize computable phenotypes for improved clinical research and operational decision-making.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Methods of Documentation VII: EMR
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Errors occurring during blood pressure monitoring
Several factors...


